Decreased expression of OATP1B1 and OATP1B3 is associated with potential resistance to anticancer drugs that rely on these transporters for cellular uptake, contributing to poor prognosis in HCC patients (Zhu et al., 2024; Wen and Zhao, 2021). This evidence concerns the gene SLCO1B3 and hepatocellular carcinoma.